After $8.3 Billion Sale to Roche (RHHBY), InterMune, Inc. (ITMN) Chief Jumps to Venture Capital http://www.biospace.com/news_story.aspx?StoryID=360327&full=1&utm_source=twitterfeed&utm_medium=twitter Maybe Don Santel should be looking over his shoulder? There was also an article on Roche cutting 170(?) of the former InterMune employees by end of February.